Published in Nat Rev Cancer on August 20, 2015
A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. Cancer Cell (2017) 1.39
Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels. J Biol Chem (2016) 0.89
Hallmarks of glycosylation in cancer. Oncotarget (2016) 0.86
The Role of Sialyl-Tn in Cancer. Int J Mol Sci (2016) 0.83
Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer. Biomolecules (2016) 0.82
Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability. EBioMedicine (2016) 0.81
The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications. Oncotarget (2016) 0.81
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells. J Proteomics (2016) 0.80
Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity. Nat Commun (2016) 0.80
An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. Nat Commun (2017) 0.80
TIMPs: versatile extracellular regulators in cancer. Nat Rev Cancer (2016) 0.79
Strategies for carbohydrate model building, refinement and validation. Acta Crystallogr D Struct Biol (2017) 0.79
Epithelial glycosylation in gut homeostasis and inflammation. Nat Immunol (2016) 0.79
Substrate specificity of FUT8 and chemoenzymatic synthesis of core-fucosylated asymmetric N-glycans. Org Biomol Chem (2016) 0.79
O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer. Oncotarget (2016) 0.79
Glycans and glycoproteins as specific biomarkers for cancer. Anal Bioanal Chem (2016) 0.79
Chemical Glycoproteomics. Chem Rev (2016) 0.78
Resolving Isomeric Glycopeptide Glycoforms with Hydrophilic Interaction Chromatography (HILIC). J Biomol Tech (2016) 0.78
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments. Front Oncol (2016) 0.77
Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment. Sci Rep (2016) 0.77
Dual Roles of O-Glucose Glycans Redundant with Monosaccharide O-Fucose on Notch in Notch Trafficking. J Biol Chem (2016) 0.77
Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer. Sci Rep (2016) 0.77
Glycosylation: a hallmark of cancer? Glycoconj J (2016) 0.77
Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer. Front Oncol (2016) 0.77
Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility. Mol Cancer Res (2016) 0.77
p53 directly regulates the glycosidase FUCA1 to promote chemotherapy-induced cell death. Cell Cycle (2016) 0.76
Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients. Oncotarget (2016) 0.76
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer. Biomolecules (2016) 0.76
Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics (2016) 0.76
Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer. Proteomics (2016) 0.76
Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies. Cell Chem Biol (2016) 0.76
Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes. Sci Rep (2016) 0.76
The Effect of Polysialic Acid Expression on Glioma Cell Nano-mechanics. Bionanoscience (2016) 0.76
The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer (2016) 0.76
Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions. Glycobiology (2016) 0.76
Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios. J Cancer (2017) 0.75
GlycoMine(struct): a new bioinformatics tool for highly accurate mapping of the human N-linked and O-linked glycoproteomes by incorporating structural features. Sci Rep (2016) 0.75
Detection of colorectal dysplasia using fluorescently labelled lectins. Sci Rep (2016) 0.75
Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway. Oncogenesis (2017) 0.75
The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential. J Biol Chem (2017) 0.75
Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer. Front Physiol (2017) 0.75
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer. Front Oncol (2016) 0.75
Systems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrix. Cardiovasc Res (2016) 0.75
Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochem Cell Biol (2016) 0.75
Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer. Cells (2016) 0.75
The Densely O-Glycosylated MUC2 Mucin Protects the Intestine and Provides Food for the Commensal Bacteria. J Mol Biol (2016) 0.75
Cutting back on the carbs. Proc Natl Acad Sci U S A (2016) 0.75
Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer. Oncotarget (2017) 0.75
Glycoblocks: a schematic three-dimensional representation for glycans and their interactions. Acta Crystallogr D Struct Biol (2016) 0.75
Human plasma N-glycosylation as analyzed by MALDI-FTICR-MS associates with markers of inflammation and metabolic health. Mol Cell Proteomics (2016) 0.75
Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants. Bioengineered (2016) 0.75
Glycosylation patterns and PHA-E-associated glycoprotein profiling associated with early hepatic encephalopathy in Chinese hepatocellular carcinoma patients. Am J Transl Res (2016) 0.75
Fungal lectin MpL enables entry of protein drugs into cancer cells and their subcellular targeting. Oncotarget (2017) 0.75
Reciprocal Modulation of Terminal Sialylation and Bisecting N-Glycans: A New Axis of Cancer-Cell Glycome Regulation? J Biol Chem (2016) 0.75
Sialylation regulates myofibroblast differentiation of human skin fibroblasts. Stem Cell Res Ther (2017) 0.75
Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension. Oncotarget (2016) 0.75
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol (2016) 0.75
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches. J Immunol Res (2016) 0.75
Glycosylated Notch and Cancer. Front Oncol (2016) 0.75
Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis. Biomolecules (2016) 0.75
Nesting of colon and ovarian cancer cells in the endothelial niche is associated with alterations in glycan and lipid metabolism. Sci Rep (2017) 0.75
N-Glycosylation of integrin α5 acts as a switch for EGFR-mediated complex formation of integrin α5β1 to α6β4. Sci Rep (2016) 0.75
Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes. Biomolecules (2016) 0.75
Mucin-Type O-Glycosylation in Gastric Carcinogenesis. Biomolecules (2016) 0.75
The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression. Front Oncol (2016) 0.75
Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol (2016) 0.75
A standardized method for lectin microarray-based tissue glycome mapping. Sci Rep (2017) 0.75
Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response. Clin Cancer Res (2016) 0.75
O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer. Oncotarget (2016) 0.75
Adhesion GPCRs in Tumorigenesis. Handb Exp Pharmacol (2016) 0.75
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Sci Rep (2017) 0.75
Electronic single-molecule identification of carbohydrate isomers by recognition tunnelling. Nat Commun (2016) 0.75
N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma. Sci Rep (2016) 0.75
A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis. Oncotarget (2016) 0.75
Muc5ac gastric mucin glycosylation is shaped by FUT2 activity and functionally impacts Helicobacter pylori binding. Sci Rep (2016) 0.75
Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage. Oncotarget (2017) 0.75
Development of IsoTaG, a Chemical Glycoproteomics Technique for Profiling Intact N- and O-Glycopeptides from Whole Cell Proteomes. J Proteome Res (2017) 0.75
Plant Lectins as Medical Tools against Digestive System Cancers. Int J Mol Sci (2017) 0.75
Externally controllable glycan presentation on nanoparticle surfaces to modulate lectin recognition. Nanoscale Horiz (2016) 0.75
Ocoxin oral solution(®) as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver. Oncol Lett (2017) 0.75
Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers. Int J Mol Sci (2017) 0.75
Combinatorial Discovery of Defined Substrates That Promote a Stem Cell State in Malignant Melanoma. ACS Cent Sci (2017) 0.75
Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression. Oncogene (2017) 0.75
Cancer stem cell marker glycosylation: Nature, function and significance. Glycoconj J (2017) 0.75
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Sci Rep (2017) 0.75
Site-specific characterization of N-linked glycosylation in human urinary glycoproteins and endogenous glycopeptides. Glycoconj J (2016) 0.75
Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression. Int J Mol Sci (2017) 0.75
Cancer cell death induced by nanomagnetolectin. Eur J Cell Biol (2017) 0.75
Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome. Oncotarget (2017) 0.75
Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase (FUT8) reveals that it catalyzes core fucosylation of N-glycans lacking α1,3-arm GlcNAc. J Biol Chem (2017) 0.75
Foldable glycoprobes capable of fluorogenic crosslinking of biomacromolecules. Chem Sci (2016) 0.75
Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours. Mol Oncol (2017) 0.75
Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma. Glycoconj J (2017) 0.75
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry: Mechanistic Studies and Methods for Improving the Structural Identification of Carbohydrates. Mass Spectrom (Tokyo) (2017) 0.75
Lectin from Sambucus sieboldiana abrogates the anoikis resistance of colon cancer cells conferred by N-acetylglucosaminyltransferase V during hematogenous metastasis. Oncotarget (2017) 0.75
High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma. Oncotarget (2017) 0.75
Serum N-glycome alterations in breast cancer during multi-modal treatment and follow-up. Mol Oncol (2017) 0.75
miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway. Dig Dis Sci (2017) 0.75
Mechanisms of miR-145 regulating invasion and metastasis of ovarian carcinoma. Am J Transl Res (2017) 0.75
On the origin of cancer cells. Science (1956) 49.55
Glycosylation in cellular mechanisms of health and disease. Cell (2006) 8.45
Intracellular functions of N-linked glycans. Science (2001) 8.39
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol (2006) 7.43
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell (1991) 7.29
Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science (1998) 6.99
The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer (2005) 5.98
Galectins as modulators of tumour progression. Nat Rev Cancer (2005) 5.30
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature (2015) 5.15
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res (1986) 5.05
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem (2011) 4.95
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell (2007) 4.85
Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science (2002) 4.38
Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem (1991) 4.16
Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science (2001) 4.13
Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science (2004) 3.73
Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A (2002) 3.73
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A (1998) 3.26
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol (2009) 3.22
Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta (1999) 3.17
Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta (2006) 3.09
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A (2001) 3.04
Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene (2010) 3.04
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest (2001) 2.98
Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 2.96
Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol (2006) 2.90
Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science (1987) 2.86
Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol (2012) 2.83
Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep (2006) 2.82
A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A (2002) 2.80
Integrins: roles in cancer development and as treatment targets. Br J Cancer (2004) 2.76
Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc Natl Acad Sci U S A (1968) 2.75
Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol (2011) 2.69
Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest (2005) 2.62
Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med (2000) 2.61
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology (2011) 2.56
Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci U S A (1999) 2.47
Fringe modulates Notch-ligand interactions. Nature (1997) 2.44
Metabolism, cell surface organization, and disease. Cell (2009) 2.41
Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res (1993) 2.39
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell (2014) 2.29
The repertoire of glycan determinants in the human glycome. Mol Biosyst (2009) 2.26
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J Biol Chem (2000) 2.18
The selectins and their ligands. Curr Opin Cell Biol (1994) 2.16
Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol (2014) 2.12
Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res (2005) 2.08
O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci (2010) 2.05
Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer (1988) 2.02
The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature (2014) 1.96
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics (2008) 1.94
Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines. Nat Methods (2011) 1.92
The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol (2004) 1.91
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med (1993) 1.89
Emerging principles for the therapeutic exploitation of glycosylation. Science (2014) 1.83
Sialyltransferases in cancer. Glycoconj J (2003) 1.83
Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev (2009) 1.79
Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol (2010) 1.73
Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem (2013) 1.72
Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst (1983) 1.71
Glycans as cancer biomarkers. Biochim Biophys Acta (2011) 1.66
Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta (2012) 1.64
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc Natl Acad Sci U S A (1999) 1.63
Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol (2009) 1.63
Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J Cell Biol (2010) 1.63
Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res (2002) 1.63
Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem (2012) 1.63
Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med (1995) 1.62
Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res (2008) 1.60
Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol (2011) 1.59
The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. J Biol Chem (2005) 1.59
Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci U S A (2011) 1.53
Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature (1982) 1.48
Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res (2002) 1.48
From lectin structure to functional glycomics: principles of the sugar code. Trends Biochem Sci (2011) 1.46
Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci U S A (1995) 1.44
A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science (2006) 1.44
Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J Biol Chem (2004) 1.44
Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem (1996) 1.44
Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci U S A (2002) 1.44
Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation. PLoS Genet (2010) 1.43
Cell surface protein glycosylation in cancer. Proteomics (2014) 1.42
Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem (2007) 1.40
A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci U S A (2014) 1.37
ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology (2005) 1.36
When galectins recognize glycans: from biochemistry to physiology and back again. Biochemistry (2011) 1.34
MUC1 immunotherapy. Immunotherapy (2010) 1.34
O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res (2013) 1.31
N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. J Biol Chem (2003) 1.31
Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol (1995) 1.31
Subcellular localization of the UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-mediated O-glycosylation reaction in the submaxillary gland. Proc Natl Acad Sci U S A (1994) 1.31
Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J Biol Chem (2002) 1.30
Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J (2008) 1.29
Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra-Golgi pH. FEBS Lett (2002) 1.28
O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell (2014) 1.28
O-GlcNAc profiling: from proteins to proteomes. Clin Proteomics (2014) 1.28
Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. Proc Natl Acad Sci U S A (2013) 1.26
N-glycosylation affects the molecular organization and stability of E-cadherin junctions. J Biol Chem (2006) 1.25
Regulation of integrin functions by N-glycans. Glycoconj J (2004) 1.25
Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res (2009) 1.24